Jolessa Information

What's inside Jolessa

Recent Jolessa Side Effects

Posted by mj312 about 1 month ago
I'm on my 3rd month of Jolessa. I've got about another 2 weeks until my first period, but I've been breakthrough bleeding for...

Posted by michellemoquin about 1 month ago
A friend of mine directed me to here. After reading all of the side effects I realized that a lot of what is going on with m...

Posted by medicationsdotcom 3 months ago
This month is my sixth month of Jolessa. I'm confused and hoping someone can help me. I have had no spotting up until this mo...

Jolessa in the News

Phoenix claim girls’ crown - ChronicleHerald.ca
Jolessa Robinson led the way for Digby with 22 points, while Kate Chute added 12. New Germany was paced by Bailey Himmelman’s game-high 23. ...
Sun Mar 02 05:02:14 -0500 2008

Phoenix claim girls’ crown - ChronicleHerald.ca
Jolessa Robinson led the way for Digby with 22 points, while Kate Chute added 12. New Germany was paced by Bailey Himmelman’s game-high 23. ...
Sun Mar 02 05:02:14 -0500 2008

Digby beats KES in Regional consolation - Nova News Now
Digby took the lead in the third quarter opening with an eight-point run, and ending with a couple quick lay ups from Jolessa Robinson to make it 43-41 ...
Sat Feb 16 13:03:41 -0500 2008

Jolessa Chemical Information

ethinyl estradiol - A semisynthetic estrogen. Ethinyl estradiol binds to the estrogen receptor complex and enters the nucleus, activating DNA transcription of genes involved in estrogenic cellular responses. This agent also inhibits 5-alpha reductase in epididymal tissue, which lowers testosterone levels and may delay progression of prostatic cancer. In addition to its antineoplastic effects, ethinyl estradiol protects against osteoporosis. In animal models, short-term therapy with this agent has been shown to provide long-term protection against breast cancer, mimicking the antitumor effects of pregnancy. (NCI04)

levonorgestrel - The levorotatory form of norgestrel and synthetic progestogen with progestational and androgenic activity. Levonorgestrel binds to the progesterone receptor in the nucleus of target cells, thereby stimulating the resulting hormone-receptor complex, initiating transcription, and increasing the synthesis of certain proteins. This results in a suppression of luteinizing hormone (LH) activity and an inhibition of ovulation, as well as an alteration in the cervical mucus and endometrium.